State Attorneys General Launch Multi-State Investigation Into OpenAI Ahead of Planned IPO

Key Takeaways

• State attorneys general from multiple jurisdictions have issued a subpoena to OpenAI demanding disclosure of internal documents related to consumer protection, data security, and user safety protocols
• The New York Attorney General’s office led the subpoena effort, requesting information on marketing tactics, data management procedures, protections for vulnerable populations, and AI response patterns
• Florida initiated the first state lawsuit against OpenAI, claiming the company deliberately launched a dangerous product despite warnings
• Florida authorities launched a criminal probe into ChatGPT’s potential connection to a mass shooting incident at Florida State University
• This regulatory scrutiny emerges shortly after OpenAI submitted confidential documents to the SEC for a planned initial public offering

Multiple state attorneys general have launched a coordinated investigation into OpenAI, delivering a formal subpoena to the artificial intelligence company on Friday, The Wall Street Journal confirmed. This legal action arrives as the company advances plans for going public through an initial public offering.

New York Attorney General Letitia James spearheaded the subpoena issuance. The legal demand seeks comprehensive documentation spanning numerous operational areas.

The requested materials encompass marketing and promotional activities, user interaction methodologies, management of consumer health information, services targeting elderly and underage users, neural network technologies, and corporate governance frameworks.

Investigators are particularly interested in examining AI sycophancy—a phenomenon where artificial intelligence systems demonstrate excessive agreement with user statements instead of providing objective, balanced information.

OpenAI released a statement indicating the company views the state attorneys general’s concerns with seriousness. The AI developer committed to cooperative dialogue with regulatory offices.

“AI is a new and powerful technology, and we work every day to safely bring its benefits to people in a responsible way,” an OpenAI spokesperson said.

Florida Files Lawsuit and Opens Criminal Investigation

Florida made history this month by becoming the first U.S. state to file litigation against OpenAI and its chief executive Sam Altman. The complaint alleges the organization deliberately deployed a hazardous product while disregarding safety concerns that it could cause user harm.

In April, Florida Attorney General James Uthmeier initiated a criminal investigation targeting OpenAI. This inquiry examines ChatGPT’s purported involvement in a mass shooting tragedy at Florida State University.

Law enforcement officials assert the perpetrator utilized the AI chatbot for consultation during the attack’s planning phase.

Wider Regulatory Pressure on Artificial Intelligence Firms

OpenAI isn’t alone in facing heightened oversight from state-level enforcement agencies.

Last December, 42 state attorneys general collaborated on correspondence addressed to OpenAI, Meta Platforms, Anthropic, Google, and xAI. The communication demanded enhanced protection mechanisms for at-risk populations and cautioned that AI developers may face liability for damaging chatbot responses.

California Attorney General Rob Bonta launched an independent inquiry earlier this year. His investigation examines allegations of sexually explicit content creation through xAI’s Grok chatbot, including purported images depicting women and minors.

The timing of this multi-jurisdiction subpoena presents significant challenges for OpenAI. The company submitted confidential IPO documentation to the Securities and Exchange Commission just weeks ago.

Regulatory investigations and legal challenges during this critical period may influence investor confidence and perceptions as the company approaches its anticipated public market debut.

OpenAI declined to provide further commentary beyond its original public statement.